Having trouble accessing articles? Reset your cache.

FDA posts Aranesp briefing documents

FDA posted briefing documents ahead of Monday's Cardiovascular and Renal Drugs Advisory Committee meeting to discuss the Phase III TREAT trial of anemia drug

Read the full 244 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE